title: New migraine therapies promise prevention: A new generation of drugs could avert migraine attacks rather than merely relieve symptoms.
authors.affiliation: London, UK.
authors.forename: Philip
authors.initials: P
authors.lastname: Hunter
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015740:Calcitonin Gene-Related Peptide / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology / Q000517:prevention & control*; D018015:Receptors, Calcitonin Gene-Related Peptide / Q000276:immunology / Q000378:metabolism; D018170:Sumatriptan / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D018015:Receptors, Calcitonin Gene-Related Peptide; D014662:Vasoconstrictor Agents; D018170:Sumatriptan; D015740:Calcitonin Gene-Related Peptide